Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pulsetto has developed a wearable, non-invasive vagus nerve stimulation device intended to reduce stress, improve sleep quality, and support mental well-being. The company claims over $10M in revenue in 2024 with nearly 40,000 orders processed and more than 100,000 users. While user feedback suggests benefits for stress relief and sleep improvement, there are currently no peer-reviewed clinical studies directly validating the efficacy of Pulsetto’s specific device. The company has raised significant funding to expand research—including into defense/military applications—and accelerate clinical trials to substantiate its health claims.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pulsetto.